Stockwinners Market Radar for January 21, 2019 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

CAG

Hot Stocks

14:06 EDT Conagra exploring alternatives for Italian-based frozen pasta business - Conagra Brands announced that it is exploring strategic alternatives for its Italian-based frozen pasta business, Gelit, which is headquartered in Doganella di Ninfa, Italy. Gelit is a producer of Italian frozen food and ready meals, primarily for private label customers. The business employs approximately 145 full-time employees. Conagra Brands has engaged BNP Paribas to assist with this process. The company added in a statement, "Conagra Brands has not set a timetable for the strategic process nor has it made any decisions relating to any strategic alternatives at this time, and no assurance can be given as to the outcome of the process. Conagra Brands does not intend to disclose additional details unless and until further disclosure is appropriate or necessary."
UQM

Hot Stocks

13:05 EDT UQM Technologies acquired by Danfoss Power Solutions for $1.71 per share - UQM Technologies announced that it has entered into a definitive merger agreement with the Danfoss Power Solutions Company, a wholly-owned subsidiary of Denmark-based Danfoss A/S, under which Danfoss will acquire all outstanding common shares of UQM for $1.71 per share in an all-cash transaction valued at approximately $100M, including the assumption of UQM's debt. The merger anticipates that UQM will become part of the Danfoss Power Solutions segment. The cash consideration represents a premium of approximately 52.5% over UQM's closing share price on January 18 and a 71.4% premium to its weighted average trading price over the trailing 60 days. The transaction will be funded with Danfoss' cash on hand and is not subject to any financing condition. The merger agreement was unanimously agreed to by the boards of both UQM and Danfoss; GDG Green Dolphin, which holds approximately 7.4% of the issued and outstanding shares of UQM, and all UQM directors and officers have executed voting and support agreements in favor of the acquisition. Closing of the transaction is subject to approval by two-thirds of UQM shareholders and by the Committee on Foreign Investment in the United States as well as other customary closing conditions. The transaction is expected to close in Q2 of 2019, subject to approval by UQM's shareholders and CFIUS.
SNY

Hot Stocks

12:37 EDT Sanofi granted U.K. marketing authorization for TIV High Dose - U.K. marketing authorization has been granted for Sanofi Pasteur's Trivalent Influenza Vaccine High Dose, which is indicated for active immunisation of people 65 years of age and older against influenza disease. The decision means the U.K. is the only European country where TIV High Dose is approved, Sanofi said in a statement. TIV High Dose is included in the Joint Committee on Vaccination and Immunisation advice on influenza vaccines for the 2019/20 influenza season. TIV High Dose is already approved for people 65 years of age and older in the United States, Canada, Australia and Brazil.
RTN

Hot Stocks

12:33 EDT Raytheon awarded $24.36M order for F/A-18 aircraft system repair - Raytheon said it was a awarded $24.36M contract for ceiling-priced delivery order N00383-19-F-N700 under previously awarded basic ordering agreement for the repair of the APG 65/73 radar systems in support of the F/A-18 aircraft. Fiscal 2019 working capital funds in the amount of $11.94M will be obligated at the time of award and funds will not expire at the end of the current fiscal year. Naval Supply Systems Command Weapon Systems Support, Philadelphia, Pennsylvania, is the contracting activity.
IBCP

Hot Stocks

11:26 EDT Independent Bank boosts quarterly dividend by 20% to 18c - Independent Bank announced that today its board declared a quarterly cash dividend on its common stock of 18c per share. This dividend is payable on Feb. 15, 2019 to shareholders of record on Feb. 5, 2019. Brad Kessel, the President and CEO of Independent Bank Corporation, commented: "We are pleased to announce a 20% increase in our quarterly cash dividend to 18 cents per share from our previous 15 cents per share level. This increase reflects the confidence of our Board of Directors in the prospects for the Company in 2019 and beyond."
EDIT

Hot Stocks

11:25 EDT Editas Medicine announces publication of EDIT-101 data in Nature Medicine - Editas Medicine announced the journal Nature Medicine published the pre-clinical data demonstrating the pharmacology and specificity of EDIT-101, an experimental, CRISPR genome editing medicine being investigated for the treatment of Leber congenital amaurosis 10, a genetically-driven form of blindness. "EDIT-101 is set to be the first in vivo, or editing inside the body, CRISPR-based medicine administered to people anywhere in the world," the company said in a statement. Published results detail the development of EDIT-101, an experimental genome editing medicine designed to remove the abnormal splice donor created by the IVS26 mutation in the CEP290 gene found in LCA10 patients and restore normal CEP290 expression. The paper summarizes in vitro experiments in human cells and retinal explants demonstrating the molecular mechanism of action and nuclease specificity.
GOOG GOOGL

Hot Stocks

11:23 EDT France's National Data Protection Commission fines Google 50M euros - France's National Data Protection Commission imposed a financial penalty of 50M euros against Alphabet's Google, in accordance with the General Data Protection Regulation, for "lack of transparency, inadequate information and lack of valid consent regarding the ads personalization." The agency explained in a statement, "On 25 and 28 May 2018, the National Data Protection Commission received group complaints from the associations None Of Your Business and La Quadrature du Net. LQDN was mandated by 10 000 people to refer the matter to the CNIL. In the two complaints, the associations reproach GOOGLE for not having a valid legal basis to process the personal data of the users of its services, particularly for ads personalization purposes." On the basis of the inspections carried out, the CNIL's restricted committee responsible for examining breaches of the Data Protection Act observed two types of breaches of the GDPR. The agency added, "This is the first time that the CNIL applies the new sanction limits provided by the GDPR. The amount decided, and the publicity of the fine, are justified by the severity of the infringements observed regarding the essential principles of the GDPR: transparency, information and consent." Reference Link
ABT

Hot Stocks

09:50 EDT Abbott announces FDA approval of TactiCath Contact Force Ablation Catheter - Abbott announced FDA approval of the TactiCath Contact Force Ablation Catheter, Sensor Enabled, a new ablation catheter "designed to help physicians accurately and effectively treat atrial fibrillation." The company added, "The approval further expands Abbott's portfolio of cardiac ablation tools that integrate with the company's EnSite Precision cardiac mapping system to help physicians develop more precise images of the heart during cardiac ablation procedures."
SFUN

Hot Stocks

09:48 EDT Fang announces management changes, proposed China Index spin-off - Fang Holdings announced a change in its senior management and a proposed spin-off of China Index Holdings Limited, a wholly-owned subsidiary of Fang. Jian Liu, Fang's President, has been appointed as CEO to replace Vincent Tianquan Mo, effective immediately. Mo will continue to serve as the Chairman of Fang's board of directors. Zijin Li, Fang's deputy CFO, has been appointed as acting CFO and Board Secretary to replace Hua Lei, effective immediately. Dr. Lei will serve as Fang's Chief Investment Officer, going forward. In addition, Fang said it "currently contemplates a spin-off of CIH to explore different options, including a potential distribution of CIH's ordinary shares to Fang's shareholders, or a potential private sale of CIH's ordinary shares, or a potential listing of CIH on a major stock exchange in the Unites States or other global stock exchanges including Chinese domestic exchanges." CIH has submitted a draft registration statement on Form F-1 on a confidential basis to the SEC for a possible initial public offering of American depositary shares representing ordinary shares of CIH.
TS

Hot Stocks

09:45 EDT Tenaris closes acquisition of 47.79% of Saudi Steel Pipe shares - Tenaris S.A. announced that it closed its previously announced acquisition from a private group of 47.79% of the shares of Saudi Steel Pipe Company, a welded steel pipes producer listed on the Saudi stock market, for a total amount of $141M. Upon the closing of the transaction, four Tenaris's nominees were appointed as new members of SSP's board of directors. In addition, SSP's board of directors appointed Mariano Armengol, a senior executive with Tenaris, as managing director and chief executive officer of SSP. Tenaris will begin consolidating SSP's results as from January 21, 2019. As a result of the transaction, Tenaris expects to expand its industrial presence in the Kingdom of Saudi Arabia. "Since its first industrial investment in the Kingdom in 2010, Tenaris has continuously invested to expand its local operations, supporting the industrialization of the country," it said in a statement.
PAAS

Hot Stocks

09:42 EDT Pan American reports 2018 silver production 24.8M ounces - Pan American Silver Corp. announced preliminary operating results for Q4 and full year 2018, and provided guidance for 2019. It said, "Silver production of 24.8 million ounces was modestly below the original guidance range provided in January 2018 of 25.0 million to 26.5 million ounces, primarily due to shortfalls at Dolores and San Vicente, partially offset by higher-than-forecast production at La Colorada and Morococha, both of which set annual records. At Dolores, above average rainfalls during the third quarter hampered our ability to make-up open pit tonnages following the security-related road closures in June, resulting in a shortfall of tonnes placed on the heap. In addition, slower cement deliveries due to logistical challenges required lower solution application and reduced leach rates. At San Vicente, narrow vein mechanization efforts required additional operator training, resulting in lower throughput and increased dilution." It said gold production of 178.9 thousand ounces was within the original guidance range. For 2019, Pan American sees silver production 26.5-27.5 million ounces.
CRWS

Hot Stocks

09:38 EDT Crown Crafts announces retirement of NoJo Baby & Kids CEO - Crown Crafts (CRWS) announced that Nanci Freeman, the President and CEO of the company's subsidiary, NoJo Baby & Kids, will be retiring on August 30, 2019. Freeman has been promoted to serve until her retirement date as Executive Chairperson of NoJo and Donna Sheridan has been named NoJo's new President and CEO. Sheridan most recently served for more than eight years as Senior Vice President of Lambs & Ivy. Prior to that, she served for almost fifteen years in senior leadership roles in merchandising, brand management and sales with Disney (DIS).
AL BA

Hot Stocks

09:36 EDT Air Lease announces lease placement of Boeing 737 MAX 9 - Air Lease (AL) announced the lease placement of one new Boeing (BA) 737 MAX 9 aircraft on long-term lease with Samoa Airways. The aircraft will feature two CFM LEAP-1B27 engines and is scheduled to deliver in Spring 2019 from Air Lease's order book with Boeing, the company said in a statement. "ALC is pleased to announce this Boeing 737 MAX 9 placement with new customer, Samoa Airways," said Steven F. Udvar-Hazy, Executive Chairman of Air Lease Corporation. "The 737 MAX 9 will enhance Samoa Airways' signature experience in the air and contribute to the airline's growing route network."
UTSI

Hot Stocks

09:34 EDT UTStarcom says TDI paid $4.54 per share to increase stake to 9.9% - UTStarcom announced that its strategic partner Tongding Interconnection Information increased its ownership stake in UT to 9.9% through a series of transactions executed late in 2018. TDI paid approximately $4.54 per share of UT, an approximately 30% premium over UT's average share price for the past three months. UTStarcom's CEO Tim Ti commented, "We are pleased to further strengthen ties with our strategic partner TDI. The fact that TDI increased its position in UT, paying a substantial premium to market, is an indication of their confidence in our shared prospects. We expect TDI's strategic investment in our company to result in compelling benefits from a market and product standpoint. Our technology and service expertise in overseas markets, especially Asia-Pacific, can significantly enhance their competitive position. Furthermore, together we can capture additional 5G network opportunities. Our technical strength in optical networking will help TDI further expand its presence in the network transmission markets, including mobile backhaul, and metro transmission." As announced in September 2018, UTStarcom formed a strategic partnership with TDI to jointly market and distribute the respective companies' products and services in China and international markets.
VRTX

Hot Stocks

09:31 EDT Vertex says European Commission granted label extension for Orkambi - Vertex Pharmaceuticals announced that the European Commission has granted approval of the label extension for Orkambi for the treatment of children with cystic fibrosis aged two to five years old who have two copies of the F508del mutation, the most common form of the disease. "Today's approval by the European Commission brings us one step closer to our goal of bringing treatment to all people living with CF," said Reshma Kewalramani, MD, Executive Vice President, Global Medicines Development and Medical Affairs and Chief Medical Officer at Vertex. ''By treating the underlying cause of disease early, we can potentially modify its course and offer patients the chance of improved outcomes.'' Orkambi is already approved in the EU for the treatment of CF in patients aged 6 and older who have two copies of the F508del mutation.
ALNY

Hot Stocks

09:30 EDT Alnylam, Israel's Medison partner to commercialize Onpattro, RNAi portfolio - Alnylam Pharmaceuticals and Israel's Medison Pharma announced an exclusive agreement to commercialize Onpattro as well as other investigational therapeutics under development in the Alnylam RNAi portfolio. "Our partnership with Medison marks an important step in our global commercial expansion and signals our intent to ensure that patients suffering from serious rare diseases have access to our medicines, regardless of location," said Theresa Heggie, SVP and Head of Europe, Middle East and Africa, and Canada, Alnylam Pharmaceuticals. The agreement between Alnylam and Medison includes Onpattro, approved in the European Union in August 2018 for the treatment of hATTR amyloidosis in adults with stage one or stage two polyneuropathy; givosiran, a late-stage investigational RNAi therapeutic for the treatment of acute hepatic porphyria; and lumasiran, a late-stage investigational RNAi therapeutic for the treatment of Primary Hyperoxaluria Type 1. These medicines are not currently approved for use in Israel and givosiran and lumasiran have not yet been approved by any regulatory authority, Alnylam noted.
THO

Hot Stocks

09:26 EDT Thor finalizing talks to exclude EHG's North American operations from deal - Thor Industries provided an update on its pending acquisition of the Erwin Hymer Group. The company announced that Thor and the sellers are finalizing discussions to exclude EHG's North American operations from Thor's purchase of EHG. Thor and EHG are currently negotiating appropriate revisions to the terms of the stock purchase agreement including adjustments to the purchase price and assumed liabilities as a consequence of the exclusion of EHG's North American operations, the company said. Upon completion of the current negotiations, Thor will provide an update regarding the changes to the financial terms of the agreement resulting from the exclusion of the EHG's North American operations from the transaction. The revised terms are expected to include, among other things, both a reduction in the purchase price and a reduction in the obligations the company would have otherwise assumed under the terms of the original stock purchase agreement, as well as a reduction in the acquisition financing debt the Company has syndicated to fund the purchase. The equity consideration component of the purchase price is not anticipated to change and the negotiated adjustments are expected to be made within the terms of the company's committed acquisition debt financing agreements.